AI assistant
Sending…
CVS HEALTH Corp — Director's Dealing 2012
May 14, 2012
29875_dirs_2012-05-14_d79c10c0-5a2c-4d63-9e36-be44386aa7ac.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CVS CAREMARK CORP (CVS)
CIK: 0000064803
Period of Report: 2012-05-11
Reporting Person: SGARRO DOUGLAS A (EVP and CLO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-05-11 | Common Stock | M | 35043 | $41.17 | Acquired | 35257.1895 | Direct |
| 2012-05-11 | Common Stock | S | 35043 | $46.1743 | Disposed | 214.1895 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-05-11 | Stock Option | $41.17 | M | 35043 | Disposed | 2015-04-01 | Common Stock (35043) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock (restricted) | 91382 | Direct |
| ESOP Common Stock | 2211.8523 | Indirect |
| Stock Unit | 14681 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option | $28.10 | 2016-04-01 | Common Stock (0) | 0 | Direct |
| Stock Option | $34.96 | 2018-04-01 | Common Stock (70336) | 70336 | Direct |
Footnotes
F1: All sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
F2: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $46.17 and $46.18 per share.
F3: Option became exercisable in three equal annual installments, commencing 4/1/2009.
F4: Option became exercisable in three equal annual installments, commencing 4/1/2010.
F5: Option becomes exercisable in four equal annual installments, commencing 4/1/2012.
More from CVS HEALTH Corp
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 18
Regulatory Filings
2026
May 7
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 6
Major Shareholding Notification
2026
Apr 30
Annual Report
2026
Apr 3
Proxy Solicitation & Information Statement
2026
Apr 3
Proxy Solicitation & Information Statement
2026
Apr 3